文献速递心胸血管麻醉术前评估与围术期医学疼痛医学

围术期长期使用普瑞巴林与氯胺酮预防心脏手术后持续性疼痛

Prolonged Perioperative Use of Pregabalin and Ketamine to Prevent Persistent Pain after Cardiac Surgery.
PubMed 文献 · Anesthesiology · 2019-01-01

这项在英国两个心脏手术中心开展的随机双盲安慰剂对照试验,纳入150例无慢性疼痛的择期胸骨正中切开心脏手术成人患者,比较常规护理、单用普瑞巴林(术前150 mg,术后14天每日两次)及普瑞巴林联合术后48小时静脉氯胺酮(0.1 mg·kg·h)对术后3个月和6个月临床显著疼痛(三次最大咳嗽后数字评分≥4分)的影响。结果显示,单用普瑞巴林和联合氯胺酮组的持续性疼痛发生率均显著低于对照组,双视更常见于两个活性治疗组。

要点

  • 术前150 mg普瑞巴林并术后14天每日两次,可显著降低心脏手术后3个月和6个月持续性疼痛发生率。
  • 联合术后48小时静脉氯胺酮0.1 mg·kg·h进一步降低6个月疼痛发生率至0%。
  • 两个活性治疗组双视发生率均高于对照组,需关注安全性。

核心结论

  • 术前给予150 mg普瑞巴林并术后继续每日两次共14天,可显著降低心脏手术后持续性疼痛的患病率。

研究设计与样本

  • 随机、双盲、安慰剂对照试验,在英国两个心脏手术中心开展。
  • 纳入150例无慢性疼痛、接受择期胸骨正中切开心脏手术的成人患者,按意向治疗分析。
  • 随机分为常规护理组、单用普瑞巴林组(术前150 mg,术后每日两次共14天)及普瑞巴林联合术后48小时静脉氯胺酮0.1 mg·kg·h组。

主要发现

  • 双视在两个活性治疗组中更常见。

临床怎么用

  • 对于无慢性疼痛的择期胸骨正中切开心脏手术成人患者,可考虑术前150 mg普瑞巴林并术后每日两次共14天以降低持续性疼痛风险。
  • 联合术后48小时静脉氯胺酮0.1 mg·kg·h可能进一步降低长期疼痛发生率,但需权衡双视等不良反应。

局限性

  • 研究仅在英国两个心脏手术中心开展,外部推广性需进一步验证。
  • 联合氯胺酮组6个月疼痛分析时样本量仅5例,结果解释需谨慎。
  • 原文未报告其他安全性指标及长期神经病理性疼痛、阿片类药物使用等次要结局的具体数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistent postsurgical pain is common and affects quality of life. The hypothesis was that use of pregabalin and ketamine would prevent persistent pain after cardiac surgery. METHODS: This randomized, double-blind, placebo-controlled trial was undertaken at two cardiac surgery centers in the United Kingdom. Adults without chronic pain and undergoing any elective cardiac surgery patients via sternotomy were randomly assigned to receive either usual care, pregabalin (150 mg preoperatively and twice daily for 14 postoperative days) alone, or pregabalin in combination with a 48-h postoperative infusion of intravenous ketamine at 0.1 mg · kg · h. The primary endpoints were prevalence of clinically significant pain at 3 and 6 months after surgery, defined as a pain score on the numeric rating scale of 4 or higher (out of 10) after a functional assessment of three maximal coughs. The secondary outcomes included acute pain, opioid use, and safety measures, as well as long-term neuropathic pain, analgesic requirement, and quality of life. RESULTS: In total, 150 patients were randomized, with 17 withdrawals from treatment and 2 losses to follow-up but with data analyzed for all participants on an intention-to-treat basis. The prevalence of pain was lower at 3 postoperative months for pregabalin alone (6% [3 of 50]) and in combination with ketamine (2% [1 of 50]) compared to the control group (34% [17 of 50]; odds ratio = 0.126 [0.022 to 0.5], P = 0.0008; and 0.041 [0.0009 to 0.28], P < 0.0001, respectively) and at 6 months for pregabalin alone (6% [3 of 50]) and in combination with ketamine 0% (0 of 5) compared to the control group (28% [14 of 50]; odds ratio = 0.167 [0.029 to 0.7], P = 0.006; and 0.000 [0 to 0.24], P < 0.0001). Diplopia was more common in both active arms. CONCLUSIONS: Preoperative administration of 150 mg of pregabalin and postoperative continuation twice daily for 14 days significantly lowered the prevalence of persistent pain after cardiac surgery.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Anwar S, Cooper J, Rahman J, et al. Prolonged Perioperative Use of Pregabalin and Ketamine to Prevent Persistent Pain after Cardiac Surgery. Anesthesiology. 2019. PMID: 31149930. doi:10.1097/ALN.0000000000002751

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。